Reduction of Normal Tissue (NT) Toxicity in Patients with Locally Advanced (LA) NSCLC treated with Concurrent Chemotherapy (ChT) and Proton Beam Therapy (PBT) compared to Intensity Modulated Radiation Therapy (IMRT)

Reviewer: Curtiland Deville, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 28 de mayo del 2010

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015